Decline in Value and Impairment of Investment Securities
First written in FY2020. 5 of 12 entries say "Materialised", first in FY2020. Latest entry: FY2026.
Gunosy moved to the "Worse" side of this theme in 2020, 3 years before the typical company in this theme (2023).
The whole theme swung hardest in 2026: 35 of 81 companies on the "Worse" side.
39 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「During the consolidated fiscal year, an impairment loss of ¥60 million was recognized on available-for-sale securities.」
Impairment of investment securities continued, but the loss decreased from ¥139 million in the previous fiscal year to ¥60 million. - 2026-07-15MaterialisedRevisions to earnings forecasts
「Following an assessment of the market value, financial condition and future outlook for part of the investment securities held by a subsidiary for investment purposes, the company recorded a ¥60 million loss on valuation of investment securities due to impairment.」
The company recorded a ¥60 million valuation loss on investment securities held for investment purposes, making the risk of value declines and impairment an actual loss. - FY2025MitigatedAnnual report
「During the consolidated fiscal year, an impairment loss of ¥139 million was recognized on available-for-sale securities.」
Impairment of investment securities continued, but the loss decreased from ¥380 million in the previous fiscal year to ¥139 million. - FY2025-H1Decrease in loss on valuation of investment securitiesAnnual report
「During the first six months of the consolidated fiscal year, an impairment loss of ¥106 million was recognized on available-for-sale securities.」
Impairment of investment securities continued to occur, but the loss decreased from ¥165 million in the same period of the previous year to ¥106 million. - FY2024WorsenedAnnual report
「During the consolidated fiscal year, an impairment loss of ¥380 million was recognized on available-for-sale securities.」
Impairment of investment securities continued, and the loss increased from ¥111 million in the previous fiscal year to ¥380 million. - FY2024-Q1WorsenedAnnual report
「An impairment loss on investment securities of ¥165 million was recognized as an extraordinary loss.」
An impairment loss on investment securities of ¥165 million was recognized, resulting in an impairment loss in the current quarter that had not occurred in the same quarter of the previous year. - FY2023WorsenedAnnual report
「During the consolidated fiscal year, an impairment loss of ¥111 million was recognized on available-for-sale securities.」
Impairment of investment securities continued, and the loss increased from ¥50 million in the previous fiscal year to ¥111 million. - FY2022WorsenedAnnual report
「During the consolidated fiscal year, an impairment loss of ¥50 million was recognized on available-for-sale securities.」
Impairment of investment securities also occurred in the current fiscal year, and the loss increased from ¥12 million in the previous fiscal year to ¥50 million. - FY2022-Q3MaterialisedAnnual report
「Impairment loss on investment securities － 50」
An impairment loss on investment securities of ¥50 million was recognized during the nine-month period of the current consolidated fiscal year, and declines in the value of and impairment of investment securities continued to occur. - FY2022-Q2MaterialisedAnnual report
「Impairment loss on investment securities － 50」
An impairment loss on investment securities of ¥50 million was recognized during the six-month period of the current consolidated fiscal year, and declines in the value of and impairment of investment securities continued to occur. - FY2021MaterialisedAnnual report
「An impairment loss on investment securities of ¥12 million was recognized.」
A decline in the value of and impairment of investment securities also occurred in the current fiscal year. The loss decreased from ¥88 million in the previous fiscal year to ¥12 million. - FY2020MaterialisedAnnual report
「During the consolidated fiscal year, impairment losses were recognized on unlisted shares, and an ¥88 million loss on valuation of investment securities was recorded.」
An impairment loss on investment securities of ¥88 million was recognized following a decline in the intrinsic value of unlisted shares.